Teratogenesis Induced by Trimethoprim Sulfamethoxazole in Mice

被引:1
作者
Arshad, Madeeha [1 ]
Asmatullah [1 ]
Ara, Chaman [1 ]
Andleeb, Shagufta [2 ]
Ahmad, Naveed [3 ]
机构
[1] Univ Punjab, Dept Zool, Dev Biol Lab, Lahore, Pakistan
[2] Univ Educ, Dept Zool, Lahore, Pakistan
[3] COMSATS Inst Informat & Technol, Dept Environm Sci, Vehari Campus, Vehari, Pakistan
关键词
Teratogenesis; Trimethoprim Sulfamethoxazole; Mice; URINARY-TRACT-INFECTIONS; FOLIC-ACID ANTAGONISTS; PREGNANCY; RISK;
D O I
10.17582/journal.pjz/2018.50.5.sc2
中图分类号
Q95 [动物学];
学科分类号
071002 ;
摘要
Antibiotic therapy is the most common for treating the UTIs during gestation, Trimethoprim Sulfamethoxazole (TMP-SMX) is one of antifolate used in such therapies. Current study was done to test the ability of TMP-SMX to induce developmental defects in mice fetuses. Different concentrations of the drug, 0.00, 4.10, 8.33 and 16.66 mu g/g B.W. were administered orally to the dams on days 6-12 of gestation, and fetuses were recovered on day 18. Morphological observations of fetuses from 4.10, 8.33 and 16.66 mu g/g B.W. dose groups showed abnormalities such as skin hemorrhages, microphthalmia, limb deformities, hygromas, kyphosis, curved and short tail and fluid filled abdominal cysts. Significant increase in intrauterine growth retardation and resorptions of fetuses, with increasing dose concentration, was also observed. Morphometric observations of fetal body parts like head circumference, eye circumference, forelimb and hindlimb size and tail length demonstrated a significant (P<0.005) decrease with increasing dose concentrations in comparison with control group. The fetal body weight and CR length reduced significantly (P<0.005) in all dose group. Trimethoprim Sulfamethoxazole has significant potential to cause congenital defects in developing embryo.
引用
收藏
页码:1967 / 1970
页数:4
相关论文
共 18 条
[1]   Exposure of Pregnant Mice to Hexavalent Chromium Causes Fetal Defects [J].
Arshad, Madeeha ;
Ahmad, Naveed ;
Khalid, Muhammad ;
Asmatullah ;
Tahir, Mohammad ;
Naveed, Khadija ;
Iqbal, Asia .
PAKISTAN JOURNAL OF ZOOLOGY, 2017, 49 (04) :1383-1389
[2]   Antibacterial Medication Use During Pregnancy and Risk of Birth Defects National Birth Defects Prevention Study [J].
Crider, Krista S. ;
Cleves, Mario A. ;
Reefhuis, Jennita ;
Berry, Robert J. ;
Hobbs, Charlotte A. ;
Hu, Dale J. .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2009, 163 (11) :978-985
[3]   The teratogenic risk of trimethoprim-sulfonamides: A population based case-control study [J].
Czeizel, AE ;
Rockenbauer, M ;
Sorensen, HT ;
Olsen, J .
REPRODUCTIVE TOXICOLOGY, 2001, 15 (06) :637-646
[4]  
Dickerman J.D., 1984, PEDIAT REV, V6, P131, DOI [10.1542/pir.6-5-131, DOI 10.1542/PIR.6-5-131]
[5]  
Duarte G., 2008, REV BRAS GINECOL OBS, V76, P241
[6]  
Forna F, 2006, AIDS REV, V8, P24
[7]   Urinary tract infections during pregnancy [J].
Gilstrap, LC ;
Ramin, SM .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2001, 28 (03) :581-+
[8]   Neural tube defects in relation to use of folic acid antagonists during pregnancy [J].
Hernández-Díaz, S ;
Werler, MM ;
Walker, AM ;
Mitchell, AA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (10) :961-968
[9]  
Joanne M., 2011, CANADIAN MED ASS J, V183, P1851, DOI [10.1503/cmaj.111152, DOI 10.1503/CMAJ.111152]
[10]  
KORZENIOWSKI OM, 1995, INFECT DIS CLIN N AM, V9, P639